InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,293.58
(
1.02%
)
US TECH 100
17,749.20
(
0.96%
)
Dow Jones
39,247.60
(
0.64%
)
Brent Oil
78.46
(
3.20%
)
Bitcoin
56,196.65
(
0.26%
)
Post# of 252803
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

flatlander_60048

Send PM Follow Ignore
Followers 10
Posts 478
Boards Moderated 0
Alias Born 02/10/2006

flatlander_60048

Re: Shengli post# 112032

Thursday, 01/06/2011 6:32:39 PM

Thursday, January 06, 2011 6:32:39 PM

Post# of 252803
I can remember Merk's Januvia beating NVS' Galvus by several weeks in filing for Diabetes. NVS got an "approvable" letter but opted to never file the additional information. Instead NVS gained approval for Galvus in in many countries outside of the US but gave up on the US.

Sometimes there is an advantage to the first filer in that some degree of benchmarking may occur.

FL
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up